Friday, January 10, 2020

USFDA:


  1) Merck's Keytruda wins U.S. FDA approval for bladder cancer
Source:
 https://www.reuters.com/article/us-merck-co-fda/mercks-keytruda-wins-u-s-fda-approval-for-bladder-cancer-idUSKBN1Z72QX 

   2) U.S. FDA Approves Supplemental New Drug Application (sNDA) for Expanded Indication of MYCAMINE® (micafungin for injection) for the Treatment of Invasive Candidiasis in Pediatric Patients Less Than 4 Months of Age 
Source: 
https://www.prnewswire.com/news-releases/us-fda-approves-supplemental-new-drug-application-snda-for-expanded-indication-of-mycamine-micafungin-for-injection-for-the-treatment-of-invasive-candidiasis-in-pediatric-patients-less-than-4-months-of-age-300983804.html